Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Magnesium-dependent enzymes involved in vitamin D metabolism are a group of cytochrome P450 hydroxylases, primarily CYP2R1 and CYP27B1, that facilitate the conversion of vitamin D into its active form, 1,25-dihydroxyvitamin D (Uwitonze & Razzaque, 2018, J Am Osteopath Assoc). Magnesium serves as an essential cofactor for these enzymes, meaning that vitamin D cannot be efficiently metabolized or activated in the presence of magnesium deficiency (Zittermann, 2013, BMC Med). Additionally, the vitamin D-binding protein (VDBP) requires magnesium to transport vitamin D metabolites to target tissues like the kidneys and bones (Uwitonze & Razzaque, 2018, J Am Osteopath Assoc). Clinical evidence suggests that patients with low magnesium levels may exhibit resistance to vitamin D supplementation, as the enzymes responsible for its activation remain underactive (Reddy & Sivakumar, 1974, Lancet). Consequently, maintaining adequate magnesium levels is vital for calcium homeostasis, bone mineralization, and the prevention of metabolic bone diseases (NIH, 2022). This synergistic relationship highlights the importance of magnesium status in the therapeutic management of vitamin D deficiency and related skeletal disorders.
Magnesium acts as a necessary cofactor for the cytochrome P450 enzymes (CYP2R1, CYP27B1, CYP24A1) that catalyze the hydroxylation of vitamin D; it is also required for the transport of vitamin D by the vitamin D-binding protein (VDBP) (Uwitonze & Razzaque, 2018, J Am Osteopath Assoc).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Magnesium-dependent vitamin D hydroxylases (CYP2R1/CYP27B1/CYP24A1).